Related Experiment Videos
Estimating the mean hazard ratio parameters for clustered survival data with random clusters
1Department of Biostatistics, University of North Carolina at Chapel Hill 27599-7400, USA.
Statistics in Medicine
|September 26, 1997
Summary
This study introduces a new statistical model for analyzing clustered survival data, accounting for random effects and interactions. The method accurately estimates treatment effects in large clinical trials, like the Studies of Left Ventricular Dysfunction (SOLVD) Prevention Trial.
Area of Science:
- Biostatistics
- Clinical Trials Methodology
- Survival Analysis
Background:
- Clustered survival data present unique analytical challenges, particularly in large multi-centre clinical trials.
- Existing models may not adequately capture the complex interplay between random cluster effects and covariates.
Purpose of the Study:
- To develop and validate a latent variable hazard model for clustered survival data.
- To estimate mean hazard ratio parameters and their variances, especially in multi-centre clinical trials.
- To assess the mean treatment effect by treating participating centres as a random sample.
Main Methods:
- Utilizing a maximum pseudo-likelihood estimator for parameter estimation.
- Implementing a bootstrap sampling scheme for variance estimation.
- Applying the model to clustered survival data with random cluster effects and covariate interactions.
Main Results:
- The proposed estimators demonstrate reliable performance in simulation studies.
- The method effectively assesses mean treatment effects in the context of multi-centre trials.
- The model successfully handles interactions between random cluster effects and covariates.
Conclusions:
- The developed latent variable hazard model provides a robust framework for analyzing clustered survival data.
- This approach enhances the assessment of treatment effects in large-scale, multi-centre clinical research.
- The method is validated through simulations and a real-world data example from the SOLVD Prevention Trial.